Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties

21Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Neurological diseases represent one of the main causes of disability in human life. Conse-quently, investigating new strategies capable of improving the quality of life in neurological patients is necessary. For decades, researchers have been working to improve the efficacy and safety of mesenchymal stromal cells (MSCs) therapy based on MSCs’ regenerative and immunomodulatory properties and multilinear differentiation potential. Therefore, strategies such as MSCs preconditioning are useful to improve their application to restore damaged neuronal circuits following neurological insults. This review is focused on preconditioning MSCs therapy as a potential application to major neurological diseases. The aim of our work is to summarize both the in vitro and in vivo studies that demonstrate the efficacy of MSC preconditioning on neuronal regeneration and cell survival as a possible application to neurological damage.

Cite

CITATION STYLE

APA

Schepici, G., Gugliandolo, A., & Mazzon, E. (2022, February 1). Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23042088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free